Where and how are decisions being taken about prevention and treatment options for Covid 19?
In 2014 a new international regulatory body was convened.
The International Coalition of Medicines Regulatory Authorities—ICMRA—comprises the Heads of the regulatory authorities of countries around the world, including the New Zealand regulator Medsafe, with the World Health Organisation (WHO) as an observer.
ICMRA does not have the sanction of any governments, it is a bureaucratic alliance of medical regulators who enjoy close relationships with the global pharmaceutical industry.
It operates a shared database among all its members which it uses to harmonise and control medical choices amongst countries ensuring that all governments will receive the same advice from their regulatory bodies. It aims to control use of all human medicine including the new genetic biologic medicines and vaccines.
The ICMRA website states its strategic aims:
Regulatory convergence, alignment, and standards development of all human medicine, which will lead to harmonisation of global regulations.
Regulatory cooperation, information- and work-sharing allowing controls on products in any country to be rapidly globalised.
It further states:
During the ongoing COVID-19 pandemic, the International Coalition of Medicines Regulatory Authorities (ICMRA) is acting as a forum to support strategic coordination and international cooperation among global medicine regulatory authorities.
The aim of these activities is to expedite and streamline the development, authorisation, and availability of COVID-19 treatments and vaccines worldwide.
ICMRA members from around the world have jointly developed a statement to answer questions and reassure people about the oversight of COVID-19 vaccines.
Despite their emergency approval before safety tests have been completed, this statement explains vaccines undergo robust scientific evaluation to determine their safety, efficacy, and quality.
Through a single body, powerful commercial interests are able to work behind the scenes to hijack and harmonise the global approach to medical regulation in every country.
They are able to control the information available to governments and limit the public message.
So when you hear from the government that Medsafe (or the equivalent regulator in your country) has approved their policies as best practice, you now know that information came to the regulator via their connection an extra-governmental body located in cloud space, subject to commercial influence, that is not accountable to anyone.
